Active substances
Chlorphenamine + Ibuprofen + Pseudoephedrine
- SFDA 1
- US FDA 2
- Health Canada 6
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| PROF Cold & Flu Film coated tablet | 200,30,2 mg,mg,mg | Film-coated tablet · Oral use | 20 Blister | SAR 12.45 | Generic · OTC | Tabuk Pharmaceutical Manufacturing Company | Valid |
Indications — CHI Daman Drug Formulary
ACUTE COUGH; BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ADVIL ALLERGY SINUS | 2MG;200MG;30MG | tablet · oral | HALEON US HOLDINGS | Over-the-counter | 19 Dec 2002 |
| CHILDREN'S ADVIL ALLERGY SINUS | 1MG/5ML;100MG/5ML;15MG/5ML | suspension · oral | HALEON US HOLDINGS | Over-the-counter | 24 Feb 2004 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ADVIL COLD & SINUS CONVENIENCE PACK | 02399733 | 2 MG; 30 MG; 200 MG | KIT; TABLET · ORAL | HALEON CANADA ULC |
| ADVIL COLD & SINUS PLUS | 02248645 | 200 MG; 2 MG; 30 MG | TABLET · ORAL | HALEON CANADA ULC |
| ADVIL COLD AND SINUS NIGHTTIME | 02267632 | 2 MG; 200 MG; 30 MG | TABLET · ORAL | HALEON CANADA ULC |
| ADVIL COLD, SINUS & FLU EXTRA STRENGTH | 02471604 | 60 MG; 400 MG; 4 MG | TABLET · ORAL | HALEON CANADA ULC |
| COLD + SINUS DAYTIME COLD + SINUS NIGHTTIME | 02388030 | 2 MG; 30 MG; 200 MG | KIT; TABLET · ORAL | VITA HEALTH PRODUCTS INC |
| COLD + SINUS PLUS | 02359243 | 2.0 MG; 30.0 MG; 200.0 MG | TABLET · ORAL | VITA HEALTH PRODUCTS INC |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.